Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
5(63%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
6
75%
Ph phase_1
2
25%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
2(25.0%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Completed(1)
Other(2)

Detailed Status

Active, not recruiting3
unknown2
Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
5
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 12 (25.0%)
N/A6 (75.0%)

Trials by Status

unknown225%
completed113%
active_not_recruiting338%
recruiting225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DEVICE
Total Trials
8